Jianling Zou
Fudan University Shanghai Cancer Center(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → Epigenetic therapy inhibits metastases by disrupting premetastatic niches(2020)334 cited
- → Establishment and characterization of patient-derived tumor xenograft using gastroscopic biopsies in gastric cancer(2015)75 cited
- → Tumor copy-number alterations predict response to immune-checkpoint-blockade in gastrointestinal cancer(2020)67 cited
- → miR-215 promotes malignant progression of gastric cancer by targeting RUNX1(2015)63 cited
- → Targeting c-Myc: JQ1 as a promising option for c-Myc-amplified esophageal squamous cell carcinoma(2018)54 cited
- → A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivo(2018)53 cited
- → Serological Markers Associated With Response to Immune Checkpoint Blockade in Metastatic Gastrointestinal Tract Cancer(2019)38 cited
- → PI3K/AKT/mTOR pathway is activated after imatinib secondary resistance in gastrointestinal stromal tumors (GISTs)(2015)38 cited
- → Serological biomarkers predict immune-related adverse events and clinical benefit in patients with advanced gastrointestinal cancers(2022)35 cited
- → Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancer(2015)33 cited